Sixty years of lithium responders

Neuropsychobiology

Volumn 62, Issue 1, 2010, Pages 8-16

  Grof, Paul ^a,b  

^a Smyth Medical Centre   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biological markers; Bipolar disorders; Clinical profile; Lithium responders; Lithium, long term treatment; Offspring

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE 1 RECEPTOR; LITHIUM SALT; SEROTONIN TRANSPORTER; LITHIUM DERIVATIVE; NEUROLEPTIC AGENT;

BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDICATION; DRUG MONITORING; DRUG RESPONSE; GENETIC MARKER; HERITABILITY; HUMAN; MAINTENANCE THERAPY; MANIA; PHARMACOGENETICS; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SCHIZOPHRENIA; GENETICS; MENTAL DISORDERS; METABOLISM;

ANTIPSYCHOTIC AGENTS; HUMANS; LITHIUM COMPOUNDS; MENTAL DISORDERS;

EID: 77951973754     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314305     Document Type: Review

References (80)

1. Grof P: Has the effectiveness of lithium changed? Impact of the variety of lithium's effects. Neuropsychopharmacology 1998; 19: 183-188.
2. Garver DL, Hirschowitz J, Fleishmann R, Djuric PE: Lithium response and psychoses: a double-blind, placebo-controlled study. Psychiatry Res 1984; 12: 57-68.
3. Garver DL, Hutchinson LJ: Psychosis, lithium- induced antipsychotic response, and seasonality. Psychiatry Res 1988; 26: 279-286.
4. Sheard MH: The effect of lithium and other ions on aggressive behavior. Mod Probl Pharmacopsychiatry 1978; 13: 53-68.
5. Muller-Oerlinghausen B, Muser-Causemann B, Volk J: Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord 1992; 25: 261-270.
6. Muller-Oerlinghausen B, Felber W, Berghoefer A, Lauterbach E, Ahrens B: The impact of lithium long-term medication on suicidal behavior and mortality of bipolar patients. Arch Suicide Res 2005; 9: 307-319.
7. Tondo L, Jamison KR, Baldessarini RJ: Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann NY Acad Sci 1997; 836: 339-351.
8. Kingsbury SJ, Garver DL: Lithium and psychosis revisited. Prog Neuropsychopharmacol Biol Psychiatry 1988; 22: 249-263.
9. Lenz G, Lovrek A, Thau K, Topitz A, Denk A, Simhandl C, Wancata J, Wolf R: Lithium prophylaxis of schizoaffective disorders (in German). Wien Med Wochenschr 1987; 137: 5.
10. Cade J: Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 36: 349-352.
11. Johnson FN: The History of Lithium Therapy. London, The MacMillan Press Ltd, 1984.
12. Cade JFJ: Lithium - Past, present and future; in Johnson FN, Johnson S (eds): Lithium in Medical Practice. Baltimore, University Park Press, 1978.
13. Coats DA, Trautner EM, Gershon S: Treatment of lithium poisoning. Aust Ann Med 1957; 1: 11-15.
14. Haig A: Mental depression and the excretion of uric acid. Practitioner 1988; 41: 342-354.
15. Lange C: Periodische Depressionszustände und ihre Pathogenesis. Hamburg, Leopold Voss, 1896.
16. Akiskal H, Bourgeois M, Angst J, Post R, et al: Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 2000; 59:S5-S30.
17. Angst J, Gamma A: Prevalence of bipolar disorders: traditional and novel approaches. Clin Appr Bipol Disord 2002; 1: 10-14.
18. Baastrup PC: The use of lithium in manicdepressive psychosis. Compr Psychiatry 1963; 5: 396-408.
19. Hartigan GP: The use of lithium salts in affective disorders. Br J Psychiatry 1963; 109: 810-814.
20. Baastrup PC, Schou M: Lithium as a prophylactic agent: its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 1967; 16: 162-172.
21. Baastrup PC, Poulsen JC, Schou M: Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 1970;ii:326.
22. Schou M, Baastrup PC, Grof P, et al: Pharmacological and clinical problems of lithium prophylaxis. Br J Psychiatry 1970; 116: 615-619.
23. Grof P, Schou M, Angst J, Baastrup PC, Weis P: Methodological problems of prophylactic trials in recurrent affective disorders. Br J Psychiatry 1970; 116: 599-603.
24. Grof P: Designing long-term clinical trials in affective disorders. J Affect Disord 1994; 30: 243-255.
25. Blackwell B, Shepherd M: Prophylactic lithium: another therapeutic myth? An examination of the evidence to date. Lancet 1968;i:968-971.
26. Blackwell B: Lithium: prophylactic or panacea? Med Counterpoint 1969; 11: 52-59.
27. Angst J, Grof P, Schou M: Lithium. Lancet 1969;i:1097.
28. Schou M, Thomsen K: Lithium prophylaxis of recurrent endogenous affective disorders; in Johnson FR (ed): Lithium Research and Therapy. New York, Academic Press, 1975.
29. Grof P: Excellent lithium responders: people whose lives have been changed by lithium prophylaxis; in Birch NJ, Gallicchio VS, Becker RW (eds): Lithium: 50 Years of Psychopharmacology. Cheshire, Weidner Publishing Group, 1999.
30. Schou M, Thomsen K, Baastrup PC: Studies on the course of recurrent endogenous affective disorders. Int Pharmacopsychiatry 1970; 5: 100-106.
31. Baldessarini RJ: Frequency of diagnosis of schizophrenia versus affective disorders from 1944 to 1968. Am J Psychiatry 1970; 127: 759-763.
32. Grof P, Fox D: Admission rates and lithium therapy (letter to the editor). Br J Psychiatry 1987; 150: 264-265.
33. Lehmann HE: Clinical features of schizophrenia; in Freedman AM, Kaplan H (eds): Comprehensive Textbook of Psychiatry. Baltimore, Williams and Wilkins, 1967.
34. Klerman G: Historical perspectives on contemporary schools of psychopathology; in Millon T, Klerman GL (eds): Contemporary Directions in Psychopathology: Toward the DSM-IV. New York, Guilford Press, 1986.
35. Upadhyaya AK, Varma VK, Sankaranayanaran A: Lithium in prophylactic therapy of manic-depressive illness: biochemical correlates of response. Biol Psychiatry 1985; 20: 202-205.
36. Mendels J, Fraser A, Baron J: Intra-erythrocyte lithium ion concentration and long-term maintenance treatment. Lancet 1976;i:966.
37. Serry M: The lithium excretion test. Aust NZ J Psychiatry 1969; 3: 390-394.
38. Sullivan JL, Cavenar JO, Maltbie A: Plateletmonoaminooxidase activity predicts response to lithium in manic-depressive illness. Lancet 1977;ii:1325-1327.
39. Carroll BJ: Prediction of treatment outcome with lithium; in Cooper TN, Gershon S, Kline N, et al (eds): Lithium, Controversies and Unresolved Issues. Amsterdam, Excerpta Medica, World Congress Lecture Series, 1979.
40. Goodwin FK, Post R, Dunner DL, Gordon EK: Cerebrospinal amine metabolites in affective illness. Am J Psychiatry 1973; 130: 73-79.
41. Carman JS, Post RH, Teplitz TA, Goodwin FK: Divalent cations in predicting antidepressant response to lithium. Lancet 1974;ii:1454.
42. Baron M, Gershon ES, Rudy V, Jonas WZ, Buchsbaum M: Lithium carbonate response in depression. Arch Gen Psychiatry 1975; 32: 1107-1111.
43. Buchsbaum M, Goodwin F, Murphy D: AER in affective disorders. Am J Psychiatry 1971; 128: 19-25.
44. Maj M: The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence. Bipolar Disord 2000; 2: 93-101.
45. Maj M, Arena F, Loverno N, et al: Factors associated with response to lithium prophylaxis in DSM III major depression and bipolar disorder. Pharmacopsychiatry 1985; 18: 309-313.
46. Kruger S, Alda M, Young LT, Goldapple K, Parikh S, Mayberg H: Risk and resilience markers in bipolar disorder: brain responses to emotional challenge in bipolar patients and their healthy siblings. Am J Psychiatry 2006; 163: 257-264.
47. Grof E, Grof P, Brown GM, Downie S: Lithium effects on neuroendocrine function. Prog Neuropsychopharmacol Biol Psychiatry 1984; 8: 541-546.
48. Grof E, Grof P, Brown GM: Investigations of lithium effects on neuroendocrine function in man; in Birch NJ (ed): Lithium: Inorganic Pharmacology and Psychiatric Use. Washington, IRL Press, 1987.
49. Alda M, Grof P, Grof E: MN blood groups and bipolar disorder: evidence of genotypic association and Hardy-Weinberg disequilibrium. Biol Psychiatry 1998; 44: 361-363.
50. Grof P, Duffy A, Cavazzoni P, Grof E, Garnham J, MacDougall M, O'Donovan C, Alda M: Is response to prophylactic lithium a familial trait? J Clin Psychiatry 2002; 63: 942-947.
51. Ghaemi SN, Ko J, Goodwin FK: 'Cade's disease' and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry 2002; 47: 125-134.
52. Schulze TG, Alda M, Adli M, Akula N, Ardau R, Bui ET, Chillotti C, Cichon S, Czerski P, Del Zompo M, Detera-Wadleigh SD, Grof P, Gruber O, Hashimoto R, Hauser J, Hoban R, Iwata N, Kassem L, Kato T, Kittel- Schneider S, Kliwicki S, Kelsoe JR, Kusumi I, Laje G, Leckband SG, Manchia M, Mac- Queen G, Masui T, Ozaki N, Perlis RH, Pfennig A, Piccardi P, Richardson S, Rouleau G, Reif A, Rybakowski JK, Sasse J, Schumacher J, Severino G, Smoller JW, Squassina A, Turecki G, Young LT, Yoshikawa T, Bauer M, McMahon FJ: The international Consortium on Lithium Genetics (ConLiGen) - an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology 2010;62:72-78
53. Alda M, Grof P, Zvolsky P: Genetic factors and response to lithium treatment; in Bauer M, Grof P, Mueller-Oerlinghausen B (eds): Lithium in Neuropsychiatry: The Comprehensive Guide. London, Informa, 2006.
54. Rybakowski JK, Suwalska A, Skibinska M, Szczepankiewicz A, Leszczynska-Rodziewicz A, Permoda A, Czrski PM, Hauser J: Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry 2005; 38: 186-1170
55. Rybakowski JK, Suwalska A, Czrski PM, Dmitrzak-Weglarz M, Leszczynska-Rodziewicz A, Hauser J: Prophylactic effect of lithium in bipolar affective illness may be re lated to serotonin transporter genotype. Pharmacol Rep 2005; 57: 124-127.
56. Rybakowski JK, Suwalska A, Skibinska M, Dmitrzak-Weglarz M, Leszczynska-Rodziewicz A, Hauser J: Response to lithium prophylaxis: interaction between serotonin transporter and BDNF genes. Am J Med Genet B Neuropsychiatr Genet 2007; 144B:820-823.
57. Rybakowski JK, Dmitrzak-Weglarz M, Suwalska A, Leszczynska-Rodziewicz A, Hauser J: Dopamine D 1 receptor gene polymorphism is associated with prophylactic lithium response in bipolar disorder. Pharmacopsychiatry 2009; 42: 20-22.
58. Grof P, Lane J, MacCrimmon D, Werstiuk E, Blajchman M, Daigle L, Varma R: Clinical and laboratory correlates of the response to long-term lithium treatment; in Stromgren E, Schoua M (eds): Origin, Prevention and Treatment of Affective Disorders. London, Academic Press, 1979.
59. Grof P, Hux M, Grof E, Arato M: Prediction of response to stabilizing lithium treatment. Pharmacopsychiatry 1983; 16: 195-200.
60. Grof P, Alda M, Grof E, Fox D, Cameron P: The challenge of predicting response to stabilising lithium treatment. The importance of patient selection. Br J Psychiatry Suppl 1993; 163(suppl 21):16-19.
61. Passmore M, Garnham J, Duffy A, Munro A, Slaney C, Teehan A, Alda M: Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine. Bipolar Disord 2003; 5: 110-114.
62. Greil W, Kleindienst N, Erazo N, Müller- Oerlinghausen B: Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J Clin Psychopharmacol 1998; 18: 455-460.
63. Abou-Saleh MT, Coppen A: Who responds to prophylactic lithium? J Affect Disord 1986; 10: 115-125.
64. Abou-Saleh MT: Predictors of response to prophylactic lithium; in Birch NJ (ed): Lithium: Inorganic Pharmacology and Psychiatric Use. Washington, IRL Press, 1987.
65. Maj M, Del Vecchio M, Starace F, Pirozzi R, Kemali D: Prediction of affective psychoses response to lithium prophylaxis. Acta Psychiatr Scand 1984; 69: 37-44.
66. Damasio H, Lyon L: Lithium carbonate in the treatment of cluster headaches. J Neurol 1980; 224: 1-8.
67. Berghoefer A, Kossman AB, Mueller-Oerlinghausen B: Course of illness and pattern of recurrences in patients with affective disorders during long-term lithium prophylaxis: a retrospective analysis over 15 years. Acta Psychiatr Scand 1996; 93: 349-354.
68. Rybakowski J, Chlopocka-Wozniak M, Suwalska A: The prophylactic effect of longterm lithium administration in bipolar patients entering treatment in the 1970s and 1980s. Bipolar Disord 2001; 3: 63-67.
69. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope HG Jr, Chou JCY, Keck PE, Rhodes LJ, Swann AC, Hirschfeld RMA, Wozniak PJ, for the Divalproex Maintenance Study Group: A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 2000; 57: 481-489.
70. Kleindienst N, Engel R, Greil W: Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders. Bipolar Disord 2005; 7: 404-417. (Pubitemid 41419407)
71. Pfennig A, Schlattmann P, Alda M, Grof P, Glenn T, Muller-Oerlinghausen B, Suwalska A, Rybakowksi JK, Willich S, Bauer M, Berghoefer A: Clinical variables influencing the quality of prophylactic effectiveness of longterm lithium treatment in bipolar patients. Submitted.
72. Berghoefer A, Alda M, Mazda A, Baethge Ch, Bauer M, Bschor T, Glenn T, Grof P, Muller-Oerlinghausen B, Rybakowksi JK, Suwalska A, Pfennig A: Long-term effectiveness of lithium in bipolar disorder: a multicenter investigation of patients with typical and atypical features. J Clin Psychiatry 2008; 69: 1860-1868.
73. Grof P, Robbins W, Alda M, Berghoefer A, Vojtechovsky M, Nilsson A, Robertson C: Protective effect of pregnancy in women with lithium-responsive bipolar disorder. J Affect Disord 2000; 61: 31-39.
74. Duffy A, Alda M, Kutcher S, Fusee C, Grof P: Psychiatric symptoms and syndromes among adolescent children of parents with lithium-responsive or lithium-nonresponsive bipolar disorder. Am J Psychiatry 1998; 155: 431-433.
75. Duffy A: A prospective study of the offspring of bipolar parents responsive and nonresponsive to lithium treatment. J Clin Psychiatry 2002; 63: 1171-1178.
76. Duffy A: Does bipolar disorder exist in children? A selected review. Can J Psychiatry 2007; 52: 409-417.
77. Duffy A, Alda M, Milin R, Grof P: A consecutive series of treated affected offspring of parents with bipolar disorder: is response associated with the clinical profile? Can J Psychiatry 2007; 52: 369-375.
78. Duffy A, Alda M, Hajek T, Grof P: Early course of bipolar disorder in high-risk offspring: prospective study. Br J Psychiatry 2009; 195: 457-458.
79. Grof P: Selecting effective treatments for bipolar disorders. J Clin Psychiatry 2003; 64(suppl 5):53-61.
80. McGorry PD, Killackey E, Yung A: Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry 2008; 7: 148-156.